| Financial Year |
March 31 2023 |
| Monetary Funds |
583,180,417.92 |
| Held-for-trading Financial Assets |
132,885,665.75 |
| Notes Receivable |
1,461,108.08 |
| Accounts Receivable |
192,386,865.29 |
| Advances to Suppliers |
7,614,215.39 |
| Other Receivables |
1,309,975.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
52,705,072.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,892,836.53 |
| Total Current Assets |
984,436,156.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
182,235,860.52 |
| Under-construction Projects |
265,436,421.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
69,527,100.60 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
7,731,131.08 |
| Other Non-Current Assets |
25,378,603.49 |
| Sub-Total of Non-Current Assets |
550,364,929.36 |
| Total Assets |
1,534,801,086.11 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
122,761,040.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,285,856.40 |
| Taxes Payable |
8,449,144.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,954,356.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,472,831.14 |
| Sub-Total of Current Liabilities |
145,013,407.26 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,267,647.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,117,867.82 |
| Total Liabilities |
164,131,275.08 |
| Paid-In Capital(Or Share Stock) |
199,558,380.00 |
| Capital Surplus |
615,350,872.27 |
| Surplus Reserve |
64,146,138.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
454,214,491.21 |
| Minority Stockholder's Interest |
1,016,314.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,369,653,496.23 |
| Owner's Equity（Stockholder's Equity） |
1,370,669,811.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,534,801,086.11 |
